Cancer Profiling Global Market Is Expected To Grow At A Rate Of More Than 11% Through 2023 – 2027
7 Jun, 2023
The global cancer profiling market size is expected to grow from $10.59 billion in 2022 to $11.93 billion in 2023 at a compound annual growth rate (CAGR) of 12.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global cancer profiling market size is expected to reach $18.29 billion in 2027 at a CAGR of 11.3%.
Global Cancer Profiling Market Key Driver
The rising cancer incidence is projected to drive the growth of the cancer profiling market in the coming years. Cancer incidence refers to the number of new cancer cases in a given population during a given time period. Cancer incidence has increased as a result of urbanisation, an ageing population, changing lifestyles, and environmental and hereditary factors. Cancer profiling assists in identifying specific molecular or genetic alterations in a tumour, such as gene mutations or other changes in tumour DNA, which is beneficial in the cancer therapy cycle.
Get a sample of the global cancer profiling market reportGlobal Cancer Profiling Market Segments
The global cancer profiling market is segmented:
1) By Technology: Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization
2) By Biomarker Type: Genomic Biomarkers, Protein Biomarkers
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers
4) By Application: Research Applications, Clinical Applications, Screening, Diagnostics, Prognostics, Other Applications
5) By Geography: The regions covered in the cancer profiling market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global cancer profiling market.
Major Cancer Profiling Industry Players
Illumina Inc., Qiagen N.V., NeoGenomics Inc., Sysmex Corporation, HTG Molecular Diagnostics Inc., Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine, Roche Diagnostics, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Genscript Biotech Corporation, Tempus Labs, Hologic Inc., Predictive Oncology Inc.
Get the full global cancer profiling market report
Cancer Profiling Market Overview
Cancer profiling refers to a diagnostic procedure that is conducted to analyze the genetic information of tumor cells in the body. It provides information about certain molecular or genetic changes in a tumor, such as gene mutations or other changes in tumor DNA.
Cancer Profiling Global Market Report 2023 provides data on the global cancer profiling market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The cancer profiling market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.